Wuhan Huakang Century Medical Co. Ltd.
Wuhan Huakang Century Clean Technology Co., Ltd. provides purification system integration and sale of medical equipment and consumables services in China and internationally. It is also involved in the sale of medical equipment and consumables. In addition, the company offers integrated medical services, laboratory integrated services, and integrated electronic cleaning services, as well as medic… Read more
Wuhan Huakang Century Medical Co. Ltd. (301235) - Net Assets
Latest net assets as of June 2025: CN¥1.77 Billion CNY
Based on the latest financial reports, Wuhan Huakang Century Medical Co. Ltd. (301235) has net assets worth CN¥1.77 Billion CNY as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.78 Billion) and total liabilities (CN¥2.01 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.77 Billion |
| % of Total Assets | 46.78% |
| Annual Growth Rate | 31.52% |
| 5-Year Change | 253.14% |
| 10-Year Change | N/A |
| Growth Volatility | 68.18 |
Wuhan Huakang Century Medical Co. Ltd. - Net Assets Trend (2019–2024)
This chart illustrates how Wuhan Huakang Century Medical Co. Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Wuhan Huakang Century Medical Co. Ltd. (2019–2024)
The table below shows the annual net assets of Wuhan Huakang Century Medical Co. Ltd. from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.80 Billion | +2.83% |
| 2023-12-31 | CN¥1.75 Billion | +6.12% |
| 2022-12-31 | CN¥1.65 Billion | +179.16% |
| 2021-12-31 | CN¥592.06 Million | +15.93% |
| 2020-12-31 | CN¥510.70 Million | +11.48% |
| 2019-12-31 | CN¥458.10 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Wuhan Huakang Century Medical Co. Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 825.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥381.89 Million | 21.23% |
| Other Components | CN¥1.42 Billion | 78.77% |
| Total Equity | CN¥1.80 Billion | 100.00% |
Wuhan Huakang Century Medical Co. Ltd. Competitors by Market Cap
The table below lists competitors of Wuhan Huakang Century Medical Co. Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Regional Container Lines Public Company Limited
BK:RCL
|
$332.81 Million |
|
Hangzhou Huaxing Chuangye Communication Technology Co Ltd
SHE:300025
|
$332.87 Million |
|
Alligo AB Series B
ST:ALLIGO-B
|
$332.94 Million |
|
Betagro Public Company Limited
F:J74
|
$333.04 Million |
|
RMK Energy PT Tbk
JK:RMKE
|
$332.65 Million |
|
MARUSAN SEC.
F:9KC
|
$332.60 Million |
|
Beijing SDL Technology Co Ltd
SHE:002658
|
$332.56 Million |
|
Shandong Shanda Oumasoft CO.LTD.
SHE:301185
|
$332.54 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Wuhan Huakang Century Medical Co. Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,753,916,277 to 1,798,630,395, a change of 44,714,119 (2.5%).
- Net income of 66,809,883 contributed positively to equity growth.
- Dividend payments of 31,236,994 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥66.81 Million | +3.71% |
| Dividends Paid | CN¥31.24 Million | -1.74% |
| Other Changes | CN¥9.14 Million | +0.51% |
| Total Change | CN¥- | 2.55% |
Book Value vs Market Value Analysis
This analysis compares Wuhan Huakang Century Medical Co. Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.95x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 8.69x to 2.95x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | CN¥5.78 | CN¥50.25 | x |
| 2020-12-31 | CN¥6.45 | CN¥50.25 | x |
| 2021-12-31 | CN¥7.48 | CN¥50.25 | x |
| 2022-12-31 | CN¥15.65 | CN¥50.25 | x |
| 2023-12-31 | CN¥16.61 | CN¥50.25 | x |
| 2024-12-31 | CN¥17.03 | CN¥50.25 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Wuhan Huakang Century Medical Co. Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.71%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.91%
- • Asset Turnover: 0.40x
- • Equity Multiplier: 2.35x
- Recent ROE (3.71%) is below the historical average (8.81%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 12.81% | 9.75% | 0.76x | 1.73x | CN¥12.88 Million |
| 2020 | 10.30% | 6.91% | 0.85x | 1.75x | CN¥1.53 Million |
| 2021 | 13.74% | 9.45% | 0.69x | 2.09x | CN¥22.16 Million |
| 2022 | 6.20% | 8.62% | 0.50x | 1.43x | CN¥-62.79 Million |
| 2023 | 6.12% | 6.70% | 0.55x | 1.65x | CN¥-68.06 Million |
| 2024 | 3.71% | 3.91% | 0.40x | 2.35x | CN¥-113.05 Million |
Industry Comparison
This section compares Wuhan Huakang Century Medical Co. Ltd.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,879,733,462
- Average return on equity (ROE) among peers: 24.67%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Wuhan Huakang Century Medical Co. Ltd. (301235) | CN¥1.77 Billion | 12.81% | 1.14x | $332.66 Million |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $792.82 Million | 25.77% | 0.17x | $318.98 Million |
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | $482.51 Million | 20.84% | 0.32x | $2.79 Billion |
| Double Medical Technology Inc (002901) | $224.61 Million | 43.10% | 0.32x | $404.40 Million |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $1.42 Million | 98.49% | 2.27x | $281.14 Million |
| Lepu Medical Tech Beijing (300003) | $12.27 Billion | 14.01% | 0.69x | $2.71 Billion |
| INKON Life Technology Co Ltd (300143) | $1.81 Billion | -20.17% | 0.37x | $637.77 Million |
| Edan Instruments Inc (300206) | $1.26 Billion | 7.37% | 0.15x | $501.55 Million |
| Guangdong Biolight Meditech Co Ltd (300246) | $504.27 Million | 13.31% | 0.36x | $360.97 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.44 Billion | 2.82% | 0.20x | $267.10 Million |
| Sinocare Inc (300298) | $17.42 Million | 41.15% | 0.68x | $952.60 Million |